Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2014
03/12/2014CN102325754B Cyclic compound having hetero atom
03/12/2014CN102056919B 取代的磺酰胺衍生物 Substituted sulfonamide derivative
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/12/2014CN101903378B Aminotriazole derivatives
03/12/2014CN101720318B Quinazolin-oxime derivatives as Hsp90 inhibitors
03/12/2014CN101679350B Quinoline derivatives for treatment of inflammatory diseases
03/12/2014CN101641332B Derivatives of aminated hydroxyquinoline class for treating cancers
03/12/2014CN101558055B Spiro substituted compounds as angiogenesis inhibitors
03/12/2014CN101541785B Substituted dihydropyrazolones and use thereof as HIF-prolyl-4 -hydroxylase inhibitors
03/11/2014US8669276 Deuterium-enriched lenalidomide
03/11/2014US8669272 2,5-disubstituted piperidine orexin receptor antagonists
03/11/2014US8669259 Heterocyclic amide compounds as protein kinase inhibitors
03/11/2014US8669251 8-fluorophthalazin-1(2H)-one compounds
03/11/2014US8669234 Antiviral compounds
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/11/2014CA2743483C Tetrasubstituted pyridazine hedgehog pathway antagonists
03/11/2014CA2726686C Triazole derivatives useful for the treatment of diseases
03/11/2014CA2655801C Therapeutic or prophylactic agent for leukemia
03/11/2014CA2612612C Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/06/2014WO2014036022A1 Quinazolinone compounds and derivatives thereof
03/06/2014WO2014036016A1 Benzimidazole derivatives as itk inhibitors
03/06/2014WO2014036015A1 Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
03/06/2014WO2014035872A1 Tricyclic alkynes that interact with glucokinase regulatory protein
03/06/2014WO2014035860A1 Inhibitors of beta-secretase
03/06/2014WO2014034898A1 Pyridine derivative and medicine
03/06/2014WO2014034719A1 Quinoline derivative having tlr inhibitory activity
03/06/2014WO2014034584A1 Organic electroluminescent element, illuminator, and display device
03/06/2014WO2014034535A1 Light emitting material, compound and organic light emitting element using light emitting material
03/06/2014WO2014034092A1 Compound having indeno acridan ring structure, and organic electroluminescence element
03/06/2014WO2014033693A1 Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate
03/06/2014WO2014033631A1 N-(3-pyridyl) biarylamides as kinase inhibitors
03/06/2014WO2014033448A1 Pyrazole derivatives as p38 map inhibitors
03/06/2014WO2014032801A1 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014WO2014032398A1 Pyridazinone compound, preparation method, pharmaceutical composition and use thereof
03/06/2014WO2014032188A1 Glycosidase inhibitors and uses thereof
03/06/2014WO2014032187A1 Glycosidase inhibitors and uses thereof
03/06/2014WO2014032185A1 Glycosidase inhibitors and uses thereof
03/06/2014WO2014009966A3 An improved process for the preparation of dabigatran etexilate mesylate and its intermediates thereof
03/06/2014WO2013144931A3 Tcr/mhcii-collagen interaction inhibitors useful for the treatment of rheumatoid arthritis
03/06/2014WO2013120104A3 Modulators of methyl modifying enzymes, compositions and uses thereof
03/06/2014US20140066624 Process for the preparation of substituted pyrimidine derivatives
03/06/2014US20140066621 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/06/2014US20140066477 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
03/06/2014US20140066476 Modulators of cellular adhesion
03/06/2014US20140066459 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/06/2014US20140066453 Serine/threonine kinase inhibitors
03/06/2014US20140066443 Aminomethyl biaryl benzotriazole derivatives
03/06/2014US20140066430 Aurora kinase modulators and method of use
03/06/2014US20140066425 Androgen receptor antagonists and uses thereof
03/06/2014US20140066423 Polycyclic beta lactam derivatives for the treatment of cancer
03/06/2014US20140066422 Phenoxy-substituted pyrimidines as opioid receptor modulators
03/06/2014US20140066421 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
03/06/2014US20140066420 Heterocyclic compound
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
03/06/2014US20140066407 Fungicide Active Substance Combinations
03/06/2014US20140066404 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
03/06/2014US20140065095 Novel inhibitors
03/06/2014US20140061591 Oled devices with internal outcoupling
03/06/2014DE102012215520A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Pyridazinderivaten und Verwendung von einem oder mehreren Pyridazin-derivaten zur Herstellung kosmetischer Zubereitungen zur Bräunung der Haut Cosmetic or dermatological preparations with a content of one or more of pyridazine derivatives, and use of one or more pyridazine derivatives for the preparation of cosmetic compositions for skin tanning
03/05/2014EP2703398A1 1,4-dihydropyridine -3,5-dicarboxylate derivatives, preparation methods and uses thereof
03/05/2014EP2703388A1 Compound with acridan ring structure, and organic electroluminescent element
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014EP2702055A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
03/05/2014EP2702054A2 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
03/05/2014EP2702053A2 Novel rock inhibitors
03/05/2014EP2702052A1 17alpha-hydroxylase/c17,20-lyase inhibitors
03/05/2014EP2702051A1 Ethynyl derivatives as positive allosteric modulators of the mglur5
03/05/2014EP2702050A1 Pyrazolidin-3-one derivatives
03/05/2014EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
03/05/2014EP2702042A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/05/2014CN103620806A Light emitting element material and light emitting element
03/05/2014CN103619833A Novel compounds for organic electronic material and organic electroluminescent device using the same
03/05/2014CN103619832A Process for the manufacture of dabigatran etexilate and intermediates thereof
03/05/2014CN103619821A Compound with acridan ring structure, and organic electroluminescent element
03/05/2014CN103619820A Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/05/2014CN103619817A Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
03/05/2014CN103619170A Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
03/05/2014CN103614133A Organic electroluminescent material and preparation method thereof
03/05/2014CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN103613581A Preparation method for Dexiansoprazole
03/05/2014CN103613580A 3-hydroxyindole-2-ketone compounds for antitumor medicaments
03/05/2014CN103613579A Bilastine purifying method
03/05/2014CN103613550A Environment-friendly synthesis method for 4(3H)-quinazolinone
03/05/2014CN103613541A Preparation method of tetra-substituted olefin and its pyrazole derivatives
03/05/2014CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN102498091B Glycine compound
03/05/2014CN102276524B Preparation method of substituted picolinamide compounds
03/05/2014CN102093260B Stereospecific synthesis of piperidine derivative
03/05/2014CN101835757B Diacylglycerol acyltransferase inhibitors
03/05/2014CN101495464B Prokineticin 1 receptor antagonists
03/04/2014US8664401 N-linked hydroxamic acid derivatives useful as antibacterial agents
03/04/2014US8664400 Triphenylamine derivatives useful as fluorophores in biology, in particular for two-photon microscopy
03/04/2014US8664399 Substituted heterocyclic compounds as ion channel modulators
03/04/2014US8664379 Fused heterocyclic compounds as ion channel modulators
03/04/2014US8664257 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
03/04/2014US8664253 Imidazole derivatives useful as modulators of FAAH and as FAAH imaging agents
03/04/2014US8664247 Acyclic organonitro compounds for use in treating cancer
03/04/2014US8664246 Substituted pyridines, and use thereof as GSK3 inhibitors
03/04/2014US8664243 Sulfonamide compound and crystal thereof
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 1080